Management of the Patient Receiving Parenteral Biologic Therapy
- 1 March 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Infusion Nursing
- Vol. 29 (2) , 63-71
- https://doi.org/10.1097/00129804-200603000-00003
Abstract
Biologic therapies are becoming the preferred treatment option for many complex medical conditions, especially in the areas of oncology and immunology. Cytokines, monoclonal antibodies, and immunomodulators all have their own specific roles, clinical applications, mechanisms of action, and side effects. As newer biologic agents are approved and used for treatment, the nurse involved in the care of the patient receiving parenteral biologic therapy or in the administration of parenteral biologic therapies must know and understand the technology and mechanisms of action associated with these agents as well as guidelines for their safe administration to ensure positive patient outcomes. This article discusses biologic therapies, focusing on monoclonal antibodies used in oncology and immunology. The indications, use, and administration of parenteral biologic therapies, as well as the nursing management of the patients receiving the therapies, are presented.Keywords
This publication has 8 references indexed in Scilit:
- New Drugs for Rheumatoid ArthritisNew England Journal of Medicine, 2004
- New Perspectives and Emerging Therapies for Immune-mediated Inflammatory DisordersJournal of Infusion Nursing, 2003
- The Incidence and Management of Infusion Reactions To Infliximab: A Large Center ExperienceAmerican Journal of Gastroenterology, 2003
- Clinical Q&AClinical Journal of Oncology Nursing, 2002
- Therapeutic Applications of Monoclonal AntibodiesThe Lancet Healthy Longevity, 2002
- TNF-R1 Signaling: A Beautiful PathwayScience, 2002
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Role of Cytokines in the Pathogenesis of Inflammatory Bowel DiseaseAnnual Review of Medicine, 2000